Pelvic Floor Symptoms Across Menopausel Stages

Sponsor
Bezmialem Vakif University
Study ID
NCT07690137
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
FEMALE
Age
40 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

  • Assessment for Lower Urinary Tract Symptoms — OTHER
    Lower urinary tract symptoms will be assessed using the validated Bristol Female Lower Urinary Tract Symptoms questionnaire. Higher scores indicate greater symptom severity and poorer urinary health-related quality of life.
  • Assessment for Bowel Symptoms — OTHER
    Bowel symptoms and colorectal-anal distress will be evaluated using the Colorectal Anal Distress Inventory-8. Higher scores indicate greater symptom severity and distress related to bowel dysfunction.
  • Constipation Severity Assessment — OTHER
    Constipation severity will be assessed using the Cleveland Clinic Constipation Score. Higher scores represent more severe constipation symptoms.
  • Sexual Function Assessment — OTHER
    Female sexual function will be assessed using the Female Sexual Function Index, a validated questionnaire evaluating desire, arousal, lubrication, orgasm, satisfaction, and pain. Higher scores indicate better sexual function.

Study Details

The menopausal transition is associated with substantial hormonal alterations that may adversely affect lower urinary tract function, bowel function, and sexual health. Although these symptoms are common, few studies have comprehensively evaluated all three pelvic floor compartments across different menopausal stages. The aim of this study is to compare lower urinary tract symptoms, bowel symptoms, and female sexual function among women in the perimenopausal, early postmenopausal, and late postmenopausal stages. In addition, the relationship between menopausal stage and symptom severity will be investigated.

Key Dates

First listed
Jul 8, 2026
Start date
Jul 6, 2026
Status verified
Jul 2026
Primary completion
Sep 6, 2026
Completion
Oct 6, 2026

Study Design

Enrollment
180 participants (estimated)

Arms

  • Arm: Perimenopause
    Perimenopausal women according to STRAW+10 criteria
  • Arm: Early postmenopause
    Early postmenopausal women according to STRAW+10 criteria
  • Arm: Late postmenopause
    Late postmenopausal women according to STRAW+10 criteria

Primary Outcome Measure

Bristol Female Lower Urinary Tract Symptoms (BFLUTS) Score [ Time Frame: Baseline (single assessment) ]

Central Contacts

Find similar trials

Nationwide
Menopause trialsWomen's health trialsFertility trials

Related Studies